BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31277422)

  • 21. Morphological Distinction of Histiocytic Sarcoma from Other Tumor Types in Bernese Mountain Dogs and Flatcoated Retrievers.
    Erich SA; Constantino-Casas F; Dobson JM; Teske E
    In Vivo; 2018; 32(1):7-17. PubMed ID: 29275293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups.
    Egan C; Nicolae A; Lack J; Chung HJ; Skarshaug S; Pham TA; Navarro W; Abdullaev Z; Aguilera NS; Xi L; Pack S; Pittaluga S; Jaffe ES; Raffeld M
    Haematologica; 2020 Apr; 105(4):951-960. PubMed ID: 31439678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical prognostic factors in canine histiocytic sarcoma.
    Dervisis NG; Kiupel M; Qin Q; Cesario L
    Vet Comp Oncol; 2017 Dec; 15(4):1171-1180. PubMed ID: 27334037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of common predisposing loci to hematopoietic cancers in four dog breeds.
    Hédan B; Cadieu É; Rimbault M; Vaysse A; Dufaure de Citres C; Devauchelle P; Botherel N; Abadie J; Quignon P; Derrien T; André C
    PLoS Genet; 2021 Apr; 17(4):e1009395. PubMed ID: 33793571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Histiocytic sarcoma in the Swiss population of Bernese mountain dogs: a retrospective study of its genetic predisposition].
    Voegeli E; Welle M; Hauser B; Dolf G; Flückiger M
    Schweiz Arch Tierheilkd; 2006 Jun; 148(6):281-8. PubMed ID: 16826705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
    Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H
    Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities.
    Gilbert-Dussardier B; Briand-Suleau A; Laurendeau I; Bilan F; Cavé H; Verloes A; Vidaud M; Vidaud D; Pasmant E
    Orphanet J Rare Dis; 2016 Jul; 11(1):101. PubMed ID: 27450488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior.
    Hedan B; Thomas R; Motsinger-Reif A; Abadie J; Andre C; Cullen J; Breen M
    BMC Cancer; 2011 May; 11():201. PubMed ID: 21615919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The gain-of-function mutation E76K in SHP2 promotes CAC tumorigenesis and induces EMT via the Wnt/β-catenin signaling pathway.
    Zhang Q; Li Y; Zhao R; Wang X; Fan C; Xu Y; Liu Y; Li J; Wang S
    Mol Carcinog; 2018 May; 57(5):619-628. PubMed ID: 29323748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase.
    Ruess DA; Heynen GJ; Ciecielski KJ; Ai J; Berninger A; Kabacaoglu D; Görgülü K; Dantes Z; Wörmann SM; Diakopoulos KN; Karpathaki AF; Kowalska M; Kaya-Aksoy E; Song L; van der Laan EAZ; López-Alberca MP; Nazaré M; Reichert M; Saur D; Erkan MM; Hopt UT; Sainz B; Birchmeier W; Schmid RM; Lesina M; Algül H
    Nat Med; 2018 Jul; 24(7):954-960. PubMed ID: 29808009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of a tumor-associated activating mutation in protein tyrosine phosphatase Ptpn11 (Shp2) enhances mitochondrial metabolism, leading to oxidative stress and senescence.
    Zheng H; Li S; Hsu P; Qu CK
    J Biol Chem; 2013 Sep; 288(36):25727-25738. PubMed ID: 23884424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors Associated with Development of Histiocytic Sarcoma in Bernese Mountain Dogs.
    Ruple A; Morley PS
    J Vet Intern Med; 2016 Jul; 30(4):1197-203. PubMed ID: 27160025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
    Lee ST; Ki CS; Lee HJ
    Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies.
    Chen Y; Takita J; Hiwatari M; Igarashi T; Hanada R; Kikuchi A; Hongo T; Taki T; Ogasawara M; Shimada A; Hayashi Y
    Genes Chromosomes Cancer; 2006 Jun; 45(6):583-91. PubMed ID: 16518851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.
    Kordes M; Röring M; Heining C; Braun S; Hutter B; Richter D; Geörg C; Scholl C; Gröschel S; Roth W; Rosenwald A; Geissinger E; von Kalle C; Jäger D; Brors B; Weichert W; Grüllich C; Glimm H; Brummer T; Fröhling S
    Leukemia; 2016 Apr; 30(4):937-46. PubMed ID: 26582644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
    Asada H; Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
    J Vet Med Sci; 2015 Jun; 77(6):677-84. PubMed ID: 25715778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of the two-base insertion mutation in the TP53 gene in canine histiocytic sarcoma.
    Asada H; Tomiyasu H; Okada K; Chambers JK; Goto-Koshino Y; Uchida K; Kagawa Y; Ohno K; Tsujimoto H
    Res Vet Sci; 2019 Jun; 124():57-60. PubMed ID: 30852355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KRAS Mutations in Canine and Feline Pancreatic Acinar Cell Carcinoma.
    Crozier C; Wood GA; Foster RA; Stasi S; Liu JH; Bartlett JM; Coomber BL; Sabine VS
    J Comp Pathol; 2016 Jul; 155(1):24-8. PubMed ID: 27290644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of dysregulation of the receptor tyrosine kinases Kit, Flt3, and Met in histiocytic sarcomas of dogs.
    Zavodovskaya R; Liao AT; Jones CL; Yip B; Chien MB; Moore PF; London CA
    Am J Vet Res; 2006 Apr; 67(4):633-41. PubMed ID: 16579756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic mutations in histiocytic sarcoma identified by next generation sequencing.
    Liu Q; Tomaszewicz K; Hutchinson L; Hornick JL; Woda B; Yu H
    Virchows Arch; 2016 Aug; 469(2):233-41. PubMed ID: 27259537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.